Oncology
The Role of the Pharmacist in Hematologic Malignancies
The incidence of hematologic malignancies (leukemias, lymphomas and myelomas) in the Kingdom of Saudi Arabia (KSA) is on the rise. For example, according to the Saudi Cancer Registry, leukemia was the 5th most common cancer diagnosed in both genders between the years of 1999-2013. Hodgkin’s lymphoma accounts for 3.6% of all cancers in KSA and is the 7th most common cancer in Saudi males and the 8th most common cancer in Saudi females.
The objective of this online program is to help educate and support pharmacists in KSA in understanding the current landscape of leukemias, lymphomas, and myelomas, including current Saudi guidelines for selected malignancies.
This program is approved for the following professions: Laboratory‐Biochemistry, Radiotherapy, Nuclear Medicine, Hematology, Medical Oncology, Nuclear Medicine, Radiation Oncology, Hematological Pathology, Pharmaceutical Sciences, Clinical Pharmacy, Pharmaceutical administration and outcomes, Pharmacy.
DURATION
2 hr
PROFESSION
Pharmacy, Specialist
# OF CREDITS
1.0
ACCREDITATION
SCFHS
EXPIRY DATE
2024-07-26
The incidence of hematologic malignancies (leukemias, lymphomas and myelomas) in the Kingdom of Saudi Arabia (KSA) is on the rise. For example, according to the Saudi Cancer Registry, leukemia was the 5th most common cancer diagnosed in both genders between the years of 1999-2013. Hodgkin’s lymphoma accounts for 3.6% of all cancers in KSA and is the 7th most common cancer in Saudi males and the 8th most common cancer in Saudi females.
The objective of this online program is to help educate and support pharmacists in KSA in understanding the current landscape of leukemias, lymphomas, and myelomas, including current Saudi guidelines for selected malignancies.
This program is supported by Novartis.
Faculty
Dr. Riad al Fakih
Nora Alkhudair, reviewer
Learning objectives
Upon completion of this continuing education program, participants will be better able to:
- Describe disease burden, risk factors, signs and symptoms and treatment for leukemias.
- Describe disease burden, risk factors, signs and symptoms and treatment for lymphomas.
- Describe disease burden, risk factors, signs and symptoms and treatment for myelomas.
- Explain the role of the pharmacist in promoting optimal patient outcomes in hematologic malignancies.
Accreditation
This program is accredited by the Saudi Commission for Health Specialties for 1.0 CPD Hour(s).
Activity Accreditation Number: ACA-20230002487.
Credits are reported to the Saudi Commission for Health Specialties on a monthly basis. Please ensure that your Saudi Commission ID is accurate in your profile and allow sufficient time for credits to appear in your Mustamir account.
This program is approved for the following professions: Laboratory‐Biochemistry, Radiotherapy, Nuclear Medicine, Hematology, Medical Oncology, Nuclear Medicine, Radiation Oncology, Hematological Pathology, Pharmaceutical Sciences, Clinical Pharmacy, Pharmaceutical administration and outcomes, Pharmacy.
# of credits: 1.0 
Duration: 2 hr FAQs & HELP
MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.
All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.
The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
If you are interested in learning more about supporting one of our programs, please contact us.
If you are interested in working with MDBriefCase Group as a writer or committee member, please contact us.
To access the MDBriefCase Group privacy policy, please click here.
No, registration with MDBriefCase is free!
To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.
If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.
Please note: if you submitted multiple password resets, only the link on the most recent email is valid.
You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.
